Blauvelt, A., Draelos, Z.D., Gooderham, M., Lain, E., Moore, A.Y., Papp, K.A., Zirwas, M., Krupa, D., Burnett, P., Berk, D.R. and Chu, D.H. 2023. Efficacy and Safety of Roflumilast Foam 0.3% in Patients With Seborrheic Dermatitis in a Phase 3 Trial: Assessment of Pruritus. SKIN The Journal of Cutaneous Medicine. 7, 4 (Jul. 2023), s226. DOI:https://doi.org/10.25251/skin.7.supp.226.